Cargando…
A novel small molecule, AS1, reverses the negative hedonic valence of noxious stimuli
BACKGROUND: Pain is the primary reason people seek medical care, with chronic pain affecting ~ 20% of people in the USA. However, many existing analgesics are ineffective in treating chronic pain, while others (e.g., opioids) have undesirable side effects. Here, we describe the screening of a small...
Autores principales: | Esancy, Kali, Conceicao, Lais L., Curtright, Andrew, Tran, Thanh, Condon, Logan, Lecamp, Bryce, Dhaka, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071644/ https://www.ncbi.nlm.nih.gov/pubmed/37013580 http://dx.doi.org/10.1186/s12915-023-01573-7 |
Ejemplares similares
-
Publisher Correction: A novel small molecule, AS1, reverses the negative hedonic valence of noxious stimuli
por: Esancy, Kali, et al.
Publicado: (2023) -
A zebrafish and mouse model for selective pruritus via direct activation of TRPA1
por: Esancy, Kali, et al.
Publicado: (2018) -
An ancient neurotrophin receptor code; a single Runx/Cbfβ complex determines somatosensory neuron fate specification in zebrafish
por: Gau, Philia, et al.
Publicado: (2017) -
Multimodal pain assessment improves discrimination between noxious and non‐noxious stimuli in infants
por: van der Vaart, Marianne, et al.
Publicado: (2019) -
Suppression of Somatosensory Evoked Cortical Responses by Noxious Stimuli
por: Takeuchi, Nobuyuki, et al.
Publicado: (2019)